1. Market Research
  2. > Xenetic Biosciences plc - Product Pipeline Review - 2013

Xenetic Biosciences plc - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 40 pages

Xenetic Biosciences plc - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Xenetic Biosciences plc - Product Pipeline Review - 2013” provides data on the Xenetic Biosciences plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Xenetic Biosciences plc’s corporate website, SEC filings, investor presentations and featured press releases, both from Xenetic Biosciences plc and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Xenetic Biosciences plc - Brief Xenetic Biosciences plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Xenetic Biosciences plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Xenetic Biosciences plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Xenetic Biosciences plc’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Xenetic Biosciences plc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Xenetic Biosciences plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Xenetic Biosciences plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Xenetic Biosciences plc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Xenetic Biosciences plc and identify potential opportunities in those areas.

Table Of Contents

Xenetic Biosciences plc - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Xenetic Biosciences plc Snapshot 5
Xenetic Biosciences plc Overview 5
Key Information 5
Key Facts 5
Xenetic Biosciences plc - Research and Development Overview 6
Key Therapeutic Areas 6
Xenetic Biosciences plc - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
Xenetic Biosciences plc - Pipeline Products Glance 15
Xenetic Biosciences plc - Late Stage Pipeline Products 15
Phase III Products/Combination Treatment Modalities 15
Xenetic Biosciences plc - Clinical Stage Pipeline Products 16
Phase II Products/Combination Treatment Modalities 16
Xenetic Biosciences plc - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Xenetic Biosciences plc - Drug Profiles 18
ErepoXen 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
MyeloXen 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
Oncohist 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
SuliXen 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
InferoXen 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
Liposomal Influenza Vaccine 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Malarial Vaccine 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
PulmoXen 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Stimuxen 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
Xenetic Biosciences plc - Pipeline Analysis 28
Xenetic Biosciences plc - Pipeline Products by Therapeutic Class 28
Xenetic Biosciences plc - Pipeline Products by Target 30
Xenetic Biosciences plc - Pipeline Products by Route of Administration 31
Xenetic Biosciences plc - Pipeline Products by Molecule Type 32
Xenetic Biosciences plc - Pipeline Products by Mechanism of Action 33
Xenetic Biosciences plc - Recent Pipeline Updates 34
Xenetic Biosciences plc - Dormant Projects 37
Xenetic Biosciences plc - Locations And Subsidiaries 38
Head Office 38
Other Locations and Subsidiaries 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 40
Disclaimer 40



List of Tables

Xenetic Biosciences plc, Key Information 5
Xenetic Biosciences plc, Key Facts 5
Xenetic Biosciences plc - Pipeline by Indication, 2013 8
Xenetic Biosciences plc - Pipeline by Stage of Development, 2013 9
Xenetic Biosciences plc - Monotherapy Products in Pipeline, 2013 10
Xenetic Biosciences plc - Partnered Products in Pipeline, 2013 11
Xenetic Biosciences plc - Partnered Products/ Combination Treatment Modalities, 2013 12
Xenetic Biosciences plc - Out-Licensed Products in Pipeline, 2013 13
Xenetic Biosciences plc - Out-Licensed Products/ Combination Treatment Modalities, 2013 14
Xenetic Biosciences plc - Phase III, 2013 15
Xenetic Biosciences plc - Phase II, 2013 16
Xenetic Biosciences plc - Preclinical, 2013 17
Xenetic Biosciences plc - Pipeline by Therapeutic Class, 2013 29
Xenetic Biosciences plc - Pipeline by Target, 2013 30
Xenetic Biosciences plc - Pipeline by Route of Administration, 2013 31
Xenetic Biosciences plc - Pipeline by Molecule Type, 2013 32
Xenetic Biosciences plc - Pipeline Products by Mechanism of Action, 2013 33
Xenetic Biosciences plc - Recent Pipeline Updates, 2013 34
Xenetic Biosciences plc - Dormant Developmental Projects,2013 37
Xenetic Biosciences plc, Subsidiaries 38



List of Figures

Xenetic Biosciences plc - Pipeline by Top 10 Indication, 2013 7
Xenetic Biosciences plc - Pipeline by Stage of Development, 2013 9
Xenetic Biosciences plc - Monotherapy Products in Pipeline, 2013 10
Xenetic Biosciences plc - Partnered Products in Pipeline, 2013 11
Xenetic Biosciences plc - Pipeline by Top 10 Therapeutic Class, 2013 28
Xenetic Biosciences plc - Pipeline by Top 10 Target, 2013 30
Xenetic Biosciences plc - Pipeline by Top 10 Route of Administration, 2013 31
Xenetic Biosciences plc - Pipeline by Top 10 Molecule Type, 2013 32
Xenetic Biosciences plc - Pipeline Products by Top 10 Mechanism of Action, 2013 33



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.